Dihydroxyaluminum sodium carbonate

Peta Jejaring Molekuler

Obat Target Gen Interaksi Enzim Transporter Carrier

Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

1. Pendahuluan & Konsep

Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).

2. Sumber Data (Validasi)

Data Obat: Diekstraksi dari elemen drugbank-id dan name pada skema XML DrugBank.
Target Protein: Diambil dari elemen targets/target yang memuat polipeptida sasaran.
Genetik: Disinkronisasi dari sub-elemen gene-name dan varian snp-effects.
Genetik: Jumlah titik node dibatasi pada maksimal 10 (Slice=10) interaksi untuk menghindari tumpukan data.

3. Algoritma Visualisasi

Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.

4. Legenda Visual

Obat Utama (Pusat Analisis)

Target Protein (Mekanisme)

Gen (Faktor Genetik)

Metode ini mendukung analisis Precision Medicine dan evaluasi risiko Drug-Drug Interaction (DDI).

Profil Farmakokinetik

Waktu Paruh (Half-Life) -

Volume Distribusi -

Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

22 Data

Ursodeoxycholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Glycochenodeoxycholic Acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Glycochenodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cholic Acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Cholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Glycocholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Glycocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deoxycholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Taurocholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Taurocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Obeticholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Chenodeoxycholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Chenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Taurochenodeoxycholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tauroursodeoxycholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Tauroursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bamet-UD2	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Bamet-UD2 resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dehydrocholic acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Dehydrocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hyodeoxycholic Acid	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Hyodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dolutegravir	The serum concentration of Dolutegravir can be decreased when it is combined with Dihydroxyaluminum sodium carbonate.
Halofantrine	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.
cis-Diamminechlorocholylglycinateplatinum(II)	The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Dihydroxyaluminum sodium carbonate.
Aramchol	The serum concentration of Aramchol can be decreased when it is combined with Dihydroxyaluminum sodium carbonate.
Ox bile extract	The serum concentration of Ox bile extract can be decreased when it is combined with Dihydroxyaluminum sodium carbonate.
Technetium Tc-99m oxidronate	The serum concentration of Technetium Tc-99m oxidronate can be increased when it is combined with Dihydroxyaluminum sodium carbonate.
Phenytoin	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Roxadustat	Dihydroxyaluminum sodium carbonate can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.
Vadadustat	The serum concentration of Vadadustat can be decreased when it is combined with Dihydroxyaluminum sodium carbonate.

Referensi & Sumber

Link

TITCK Product Information: KOMPENSAN (Dihydroxyaluminum sodium carbonate) oral tablet

Contoh Produk & Brand

Produk: 0 • International brands: 3

International Brands

Daxaids
Noacid
Rolaids

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.